Provenance du réseau au premier degré de Kerry L. Spear
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Blue Oak Pharmaceuticals, Inc.
 Blue Oak Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Blue Oak Pharmaceuticals, Inc. is a therapeutics developer for brain disorders. Its research is in finding the next generation of drugs for the brain disorders to help patients by creating new medicines, transform the CNS drug discovery paradigm, and achieve rapid clinical neurobiology measures and translational biomarkers. The company was founded by Thomas H. Large and Kerry L. Spear in 2016 and is headquartered in Concord, MA.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kerry L. Spear via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Thomas Jefferson University | College/University | Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Investment Managers | Director/Board Member | |
Azkarra Therapeutics, Inc.
 Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Azkarra Therapeutics, Inc. is a medical research and development company that specializes in providing oncology therapies based on DNA damage response. The company is based in South San Francisco, CA. Mohamad Tabrizi has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| Drexel University | College/University | Graduate Degree | |
| University of Scranton | College/University | Undergraduate Degree | |
Shangpharma Corp.
 Shangpharma Corp. Pharmaceuticals: MajorHealth Technology Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 7 |
| Chine | 3 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 4 |
| Doctorate Degree | 1 |
| Private Equity Investor | 1 |
| Graduate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert A. Drakas | 9 |
| Thomas H. Large | 1 |
- Bourse
- Insiders
- Kerry L. Spear
- Connexions Sociétés
